Albert D. Dyrness
CIK 1664801 · last filed 2026-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$362.5K
Companies
3
Total Filings
13
Lifetime Open-Market Net
$20.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PURR | Director | 41,671 | $8.70 | $362.5K | $0 | 2 | 2026-02-11 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Director | 0 | $1.26 | $0 | $20.5K | 9 | 2025-12-03 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 2 | 2017-10-30 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +2,557 | $0 | EDGAR |
| 2017-10-30 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-27 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Buy (P) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.